Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer
Keyword(s):
Keyword(s):
2009 ◽
Vol 4
(11)
◽
pp. 1404-1414
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 3
(3)
◽
pp. 303-310
◽
Keyword(s):